Treatment of myelomatosis--M.R.C. trial.
D000368:Aged; D001536:Bence Jones Protein / Q000652:urine; D001806:Blood Urea Nitrogen; D002986:Clinical Trials as Topic; D003520:Cyclophosphamide / Q000627:therapeutic use*; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D006934:Hypercalcemia / Q000150:complications; D007070:Immunoglobulin A; D007074:Immunoglobulin G; D008297:Male; D008558:Melphalan / Q000627:therapeutic use*; D008875:Middle Aged; D009101:Multiple Myeloma / Q000150:complications / Q000188:drug therapy* / Q000401:mortality; D012709:Serum Albumin
D007070:Immunoglobulin A; D007074:Immunoglobulin G; D012709:Serum Albumin; D003520:Cyclophosphamide; D001536:Bence Jones Protein; D008558:Melphalan